Pupillary IOL Removal, Soemmering Removal, Akreos IOL, and Posterior Lamellar Transplant DSAEK

Ozana Moraru, MD

Eyetube

The video presents a complex procedure in an eye with history of traumatic cataract in childhood, operated at that time by intracapsular extraction and implantation of a pupillary IOL. This IOL started to harm and decompensate the corneal endothelium. The patient presented with bullous keratopathy and a recommendation for corneal transplant. Ozana Moraru, MD, prepared for a posterior lamellar transplant UT-DSAEK (ultra-thin DSAEK) and removal of the pupillary IOL. After IOL removal, Dr. Moraru also observed two large and thick halves of a Soemmering long-standing cortex remnant. A superior iridotomy due to large atrophic iris was fixed by iris suture with the Siepser technique. Since there was no capsular support, she implanted an Akreos IOL sutured at the sclera in four points using Gore-Tex sutures.

The Premium IOL Market Is Accelerating

What this means for cataract surgeons.

Wayne Caulder

Cataract and Refractive Surgery Today

Leading ophthalmic practices must embrace innovation to stay competitive. Adopting cutting-edge solutions such as premium IOLs can enhance patient outcomes and reinforce a practice’s commitment to excellence. Wayne Caulder is a trailblazer in ophthalmology whose pioneering work has helped shape patient care and surgical practices. The insights he shares in this article underscore the importance of embracing change and striving for excellence in a competitive landscape. Tracy J. Kenniff, MBA, OCS Premium IOLs have moved from the margins of cataract surgery into the mainstream of modern ophthalmic practice. What was once a niche offering is now a core growth engine for practices across the United States and a meaningful driver of patient satisfaction, practice differentiation, and long-term sustainability. Understanding why this market is expanding and how to respond thoughtfully is essential for any surgeon focused on the future. A MARKET POISED FOR CONTINUED GROWTH The United States is, by far, the largest premium cataract surgery market in the world; it accounts for approximately 36% of global manufacturer revenue.1 Of the estimated 5.2 million cataract and refractive lens exchange procedures that were expected in 2025, Market Scope projected that roughly 38%—or about 1.98 million cases—would include at least one premium component.1 Several factors explain why the US market has reached this scale. First, the country has a large and relatively affluent patient population with high expectations for visual performance.

Trends in PDR Treatments

Maria Berrocal, MD; and Katherine Talcott, MD

Eyetube

How did real-world treatment patterns for PDR change from 2016 to 2023? In this episode of Clinical Minute: Retina, host Maria Berrocal, MD, speaks with Katherine Talcott, MD, about a large database study examining shifts in laser, anti-VEGF, and combination therapy use over time. They explore demographic trends, post-COVID changes in care delivery, and how these data intersect with clinical decision-making, follow-up challenges, and long-standing treatment paradigms.